课题基金 / 基金详情

BIOCHEMICAL AND CYTOGENETIC MARKERS IN RETINOBLASTOMA

BIOCHEMICAL AND CYTOGENETIC MARKERS IN RETINOBLASTOMA
视网膜母细胞瘤的生化和细胞遗传学标志物
批准号:
3257092
负责人:
WILLIAM Francis BENEDICT
金额:
$17.3万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1988
资助国家:
美国
项目状态:
已结题
起止时间:
1988-07-01 至 1991-03-31

项目摘要

项目成果

WILLIAM Francis BENEDICT的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The authentic gene responsible for the development of both retinoblastoma (Rb) and osteosarcoma has recently been cloned within our program. Using cDNA probes of the Rb gene, structural changes (deletions and rearrangements) were observed in 16 of 40 retinoblastomas examined as well as in an osteosarcoma. Whether or not structural aberrations were found, the retinoblastomas and osteosarcomas has either an absence of the Rb transcript or an abnormal transcript. Having cloned the Rb gene and shown that it is the loss or inactivation of both alleles of the Rb gene that is responsible for retinoblastoma and osteosarcoma, our plans include determining in which other cancers the Rb gene has a role in the etiology of the tumor. Prime candidates include: 1. other tumors arising in patients with hereditary retinoblastoma, especially soft tissue sarcomas, 2. alveolar rhabdomyosarcomas, 3. hereditary breast cancer, 4. small cell carcinoma of the lung and 5. melanomas. We shall examine the Rb gene in the tumors mentioned above as well as other tumor types to determine if changes at the structural or RNA level can be identified in a similar manner as retinoblastoma and osteosarcoma. Our group fortunately has access to a unique population of tumor specimens including the largest number of cases with second malignancies in the world who have previously had retinoblastoma. These studies could have extremely important implications in understanding the basis of human cancer and in identifying several other malignancies in which the Rb gene has a key role. We shall also examine whether the Rb gene has an etiological role in additional families who have dominantly inherited predisposition to develop cancer. Finally, we shall examine all known oncogenes for their expression in retinoblastomas, osteosarcomas, and other tumor in which the Rb gene is a causative factor. Methodologies to be used include standard molecular biological and cytogenetic techniques presently available in our laboratory.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developmental Research Program
Intravesical Gene Therapy for BCG Refractory Bladder Cancer
Career Development Program
Administrative Core
海外基金